We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » COVID-19

COVID-19
COVID-19 RSS Feed RSS

NIH Shares COVID-19 Technologies With Medicines Patent Pool

May 16, 2022
The technologies are also made available through the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) program. Read More

South Africa Manufacturer Plans to Stop Making COVID-19 Vaccines

May 16, 2022
The plant has produced more than 200 million doses of COVID-19 vaccines. Read More

FDA Encourages Veru to Submit EUA Application for COVID-19 Therapy

May 13, 2022
In the wake of strongly positive data and an FDA go-ahead, Veru will seek an Emergency Use Authorization (EUA) for sabizabulin, its investigational COVID-19 therapy. Read More

Moderna Completes EUA Submission for Use of COVID-19 Vaccine in Children

May 13, 2022
Spikevax is not currently authorized or approved for children under 18. Read More

Emergent Hid Quality Problems With COVID-19 Vaccines, New Report Shows

May 12, 2022
The troubled manufacturing plant Emergent BioSolutions concealed proof of quality problems at its Baltimore, Md., location just a month and a half before it told the FDA that 15 million COVID-19 vaccine doses manufactured there had been contaminated. Read More

FDA Provides Update on Mesa Biotech’s Recall of Its Accula COVID-19 Tests

May 12, 2022
False positive results could lead to further exposure of uninfected individuals to the SARS-CoV-2 virus, the agency said. Read More

UK Study Shows Promising Data for Fourth COVID-19 Vaccine Shot

May 11, 2022
The UK currently permits people over age 75 and people who are immunosuppressed to get the fourth COVID-19 vaccine shot. Read More

FDA Open to Less Than 50 Percent Efficacy in COVID Vaccines for Smallest Kids

May 10, 2022
In a May 6 briefing before Congress, the director of the FDA’s Center of Biologics Evaluation and Research (CBER), Peter Marks, said the agency would not withhold authorization for a pediatric vaccine solely because it did not reach a 50 percent efficacy threshold at blocking symptomatic infection — a requirement that had been previously listed in FDA guidance. Read More

French Regulatory Agency to File Criminal Charges Against Didier Raoult-Led Institute

May 10, 2022
Raoult denied the gravity of the IHU’s practices. Read More

Rhinostics’ Automated Nasal Swab for COVID-19 Testing Approved by Health Canada

May 10, 2022
The swabs work with a variety of automated decappers to create hands-free workflows. Read More

Recall of Skippack Medical’s Unapproved COVID-19 Test Designated Class 1 by FDA

May 10, 2022
No false positive or negative test results were reported, the company said. Read More

WHO Recommends Veklury for COVID-19 Patients at High Risk

May 9, 2022
The WHO previously advised against using Veklury for any COVID-19 patients, regardless of disease severity. Read More
Previous 1 2 … 7 8 9 10 11 12 13 14 15 … 173 174 Next

Upcoming Events

  • 08Feb

    Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions

  • 09Feb

    The Inextricable Link Between Data Integrity and Quality Culture

  • 15Feb

    Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 22Feb

    Best Practices for Developing and Maintaining a GxP Training Matrix

  • 07Mar

    FDA’s Remote Assessments v. Remote Interactive Evaluations: Do You Really Know the Difference?

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Consortium Gets EU Funding to Develop Continuous Blood Pressure Monitoring Device

  • FDA Approves GSK’s Oral Drug for Chronic Kidney Disease-Related Anemia

  • Aspivix’s Carevix Cleared to Reduce Pain, Bleeding in Gynecological Procedures

  • FDA Warns That Energy Supplement Contains Active Cialis Ingredient

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing